CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 8-K Event Results of operations
- 4 Shares withheld for taxes Chief Scientific Officer gave up 303 shares (to pay taxes)
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Grant or award Chief Operating Officer acquired 236,360 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Financial Officer sold 30,000 shares at $19.09 ($572,835)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Other events
- 424B5 Offering Prospectus
- S-3ASR Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Financial Officer sold 30,000 shares at $15.69 ($470,622)
- 144 Insider Sale of Securities
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change
- 8-K Event Material agreement
- 4 Shares withheld for taxes Chief Legal Officer gave up 3,309 shares (to pay taxes)
- SC 13G Stake Amended Statement of Ownership
Page 15 of 104 · 2,077 filings